Form 8-K - Current report:
SEC Accession No. 0000950170-25-080234
Filing Date
2025-06-02
Accepted
2025-06-02 16:05:13
Documents
10
Period of Report
2025-05-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K atha-20250529.htm   iXBRL 8-K 62806
  Complete submission text file 0000950170-25-080234.txt   174173

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20250529.xsd EX-101.SCH 26991
12 EXTRACTED XBRL INSTANCE DOCUMENT atha-20250529_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 251014918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)